A pharmaceutically acceptable salt and solvate of n-(2-bromophenyl)-n'-[((r)-1-(5 trifluoromethyl-2-pyridyl)pyrrolidin-3 yl)]urea compound
PK140838AUndetermined Publication Date: 2010-07-07SMITHKLINE BEECHAM PLC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201000344
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-07-07
Abstract
Disclosed is a pharmaceutically acceptable salt and solvate of a compound N-(2Bromophenyl)-N’-[((R)-1-(5 trifluoromethy l-2-pyridyl)pyrrolidin-3-yl)]urea, having the formula: a pharmaceutical composition comprising such compound for the treatment or prophylaxis of disorders in which antagonism of the Vanilloid (VR1) receptor is beneficial.
Need to check novelty before this filing date? Find Prior Art